Adult-onset non-5q proximal spinal muscular atrophy: a comprehensive review

Adult-onset non-5q proximal spinal muscular atrophy: a comprehensive review

Abstract Background: Adult-onset spinal muscular atrophy (SMA) represents an expanding group of inherited neurodegenerative disorders in clinical practice. Objective: This review aims to synthesize the main clinical, genetic, radiological, biochemical, and neurophysiological aspects related to the...

Full description

Bibliographic Details
Main Authors:	Wladimir Bocca Vieira de Rezende Pinto, Paulo Victor Sgobbi de Souza, Bruno Mattos Lombardi Badia, Igor Braga Farias, José Marcos Vieira de Albuquerque Filho, Eduardo Augusto Gonçalves, Roberta Ismael Lacerda Machado, Acary Souza Bulle Oliveira
Format:	Article
Language:	English
Published:	Academia Brasileira de Neurologia (ABNEURO) 2021-01-01
Series:	Arquivos de Neuro-Psiquiatria
Subjects:	Muscular Atrophy, Spinal Neurodegenerative Diseases Motor Neuron Disease Neuromuscular Diseases
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2021001000912&tlng=en

Similar Items

In Search of a Cure: The Development of Therapeutics to Alter the Progression of Spinal Muscular Atrophy
by: Kristine S. Ojala, et al.
Published: (2021-02-01)

Innovating spinal muscular atrophy models in the therapeutic era
by: Ilaria Signoria, et al.
Published: (2023-09-01)

Nemo-like kinase is a novel regulator of spinal and bulbar muscular atrophy
by: Tiffany W Todd, et al.
Published: (2015-08-01)

Safety and Tolerability of Strength Training in Spinal and Bulbar Muscular Atrophy: A Case Report
by: Vincent Shieh, et al.
Published: (2022-08-01)

Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
by: Winkelsas, AM
Published: (2020)

Nusinersen Treatment for Spinal Muscular Atrophy: Retrospective Multicenter Study of Pediatric and Adult Patients in Kuwait
by: Asma AlTawari, et al.
Published: (2024-06-01)

Cognitive impairment in Chinese adult patients with type III spinal muscular atrophy without disease-modifying treatment
by: Ying Hu, et al.
Published: (2023-11-01)

Spinal Muscular Atrophy in Blonde D'Aquitaine Calves Is Not Associated With FVT1 Gene Mutation
by: Giulia Cagnotti, et al.
Published: (2020-06-01)

Expanding the Availability of Onasemnogene Abeparvovec to Older Patients: The Evolving Treatment Landscape for Spinal Muscular Atrophy
by: Charlotte A. René, et al.
Published: (2023-06-01)

Post-polio syndrome: renaissance of poliomyelitis?
by: Claudio Andre Barbosa de Lira, et al.
Published: (2009-03-01)

Identifying epigenetic regulators of survival motor neuron protein to treat spinal muscular atrophy
by: Kordala, A
Published: (2022)

Copy Number Variations in the Survival Motor Neuron Genes: Implications for Spinal Muscular Atrophy and Other Neurodegenerative Diseases
by: Matthew E R Butchbach, et al.
Published: (2016-03-01)

The social-economic burden of spinal muscular atrophy in Russia
by: A. S. Kolbin, et al.
Published: (2021-02-01)

Real-World Data on Access to Standards of Care for People With Spinal Muscular Atrophy in the UK
by: Robert Muni-Lofra, et al.
Published: (2022-05-01)

Pain in Children and Adolescents with Spinal Muscular Atrophy: A Longitudinal Study from a Patient Registry
by: Inmaculada Pitarch-Castellano, et al.
Published: (2023-11-01)

Changes in pNFH Levels in Cerebrospinal Fluid and Motor Evolution after the Loading Dose with Nusinersen in Different Types of Spinal Muscular Atrophy
by: Mihaela Badina, et al.
Published: (2023-07-01)

G9a promotes muscular atrophy in chronic aging and acute denervation
by: Ying Jin, et al.
Published: (2024-11-01)

The association between gait speed and falls in ambulatory adults with spinal muscular atrophy: a retrospective pilot study
by: Kathryn Jira, et al.
Published: (2024-12-01)

Physical Therapy and Nusinersen Impact on Spinal Muscular Atrophy Rehabilitative Outcome
by: Andrada Mirea, et al.
Published: (2022-06-01)

Considerations for Treatment in Clinical Care of Spinal Muscular Atrophy Patients
by: Stephanie Voight, et al.
Published: (2024-04-01)

General principles of vaccination of patients with neuromuscular diseases
by: M. S. Skorikov, et al.
Published: (2023-10-01)

Pediatric Neuromuscular Diseases Prevalence in Siriraj Hospital, Thailand's Largest Tertiary Referral Hospital
by: Apirada Thongsing, et al.
Published: (2020-01-01)

Spinal muscular atrophy
by: D'Amico Adele, et al.
Published: (2011-11-01)

Spinal muscular atrophy type 1 in the Caribbean: the first case report from the Dominican Republic
by: María Belén Martín-Sanz, et al.
Published: (2025-01-01)

Investigation on the Effects of Modifying Genes on the Spinal Muscular Atrophy Phenotype
by: Drenushe Zhuri, et al.
Published: (2022-09-01)

Pregnancy in a Patient with Spinal Muscular Atrophy and Severe Restrictive Lung Disease
by: Lamia A. Alamri, et al.
Published: (2023-07-01)

Acceptability, validity and responsiveness of inertial measurement units for assessing motor recovery after gene therapy in infants with early onset spinal muscular atrophy: a prospective cohort study
by: R. Barrois, et al.
Published: (2024-10-01)

Impact of the motor function of individuals with spinal muscular atrophy on caregiver burden
by: Natália Guimarães Melo, et al.
Published: (2023-11-01)

Clinical Practice Guideline for Adolescent & Adult Patients with Spinal Muscular Atrophy
by: Rare Disease Society of Chinese Research Hospital Association, et al.
Published: (2023-04-01)

Clinical Practice Guideline for Adolescent & Adult Patients with Spinal Muscular Atrophy
by: Rare Disease Society of Chinese Research Hospital Association, et al.
Published: (2023-07-01)

Clinical Practice Guideline for Adolescent & Adult Patients with Spinal Muscular Atrophy
by: Rare Disease Society of Chinese Research Hospital Association, et al.
Published: (2023-01-01)

The association of hand grip strength with functional measures in non-ambulatory children with Duchenne muscular dystrophy
by: Numan Bulut, et al.
Published: (2019-12-01)

Rehabilitation in spinal muscular atrophy
by: Joanna Iłżecka
Published: (2021-05-01)

Quality of Life Outcomes According to Differential Nusinersen Exposure in Pediatric Spinal Muscular Atrophy
by: Meaghann S. Weaver, et al.
Published: (2021-07-01)

The role of ubiquitination in spinal and bulbar muscular atrophy
by: Medha Sengupta, et al.
Published: (2022-10-01)

Exercise attenuates polyglutamine‐mediated neuromuscular degeneration in a mouse model of spinal and bulbar muscular atrophy
by: Tomoki Hirunagi, et al.
Published: (2024-02-01)

Lung function decline preceding chronic respiratory failure in spinal muscular atrophy: a national prospective cohort study
by: Esther S. Veldhoen, et al.
Published: (2023-02-01)

Objective measurement of oral function in adults with spinal muscular atrophy
by: T. Kruse, et al.
Published: (2023-05-01)

Estimated costs for Duchenne muscular dystrophy care in Brazil
by: Nayê Balzan Schneider, et al.
Published: (2023-06-01)

Investigating the Application of Orem’s Self-care Nursing Theory for Spinal Muscular Atrophy: A Case Study Design
by: Lo’ai Aburayyan, et al.
Published: (2024-01-01)